Connection

GUILLERMO GARCIA-MANERO to Promoter Regions, Genetic

This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Promoter Regions, Genetic.
  1. Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation. Oncogene. 2007 Mar 01; 26(10):1439-48.
    View in: PubMed
    Score: 0.170
  2. RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. Br J Haematol. 2015 May; 169(3):344-51.
    View in: PubMed
    Score: 0.076
  3. DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. Leukemia. 2014 Apr; 28(4):787-93.
    View in: PubMed
    Score: 0.069
  4. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia. 2013 Nov; 27(11):2177-86.
    View in: PubMed
    Score: 0.067
  5. Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome. BMC Med Genet. 2010 Nov 16; 11:163.
    View in: PubMed
    Score: 0.057
  6. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia. 2008 Aug; 22(8):1529-38.
    View in: PubMed
    Score: 0.048
  7. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J Clin Oncol. 2005 Jun 10; 23(17):3932-9.
    View in: PubMed
    Score: 0.039
  8. Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia. Leuk Res. 2005 Aug; 29(8):881-5.
    View in: PubMed
    Score: 0.038
  9. Prognostic implications of epigenetic silencing of p15INK4B in acute promyelocytic leukemia. Leukemia. 2003 May; 17(5):839-40.
    View in: PubMed
    Score: 0.034
  10. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res. 2002 Jul; 8(7):2217-24.
    View in: PubMed
    Score: 0.032
  11. EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System. Mol Cancer Res. 2015 Jun; 13(6):982-92.
    View in: PubMed
    Score: 0.019
  12. Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia. Am J Hematol. 2013 Sep; 88(9):784-9.
    View in: PubMed
    Score: 0.017
  13. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012 Sep 21; 337(6101):1541-6.
    View in: PubMed
    Score: 0.016
  14. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion. Neuro Oncol. 2012 Sep; 14(9):1125-35.
    View in: PubMed
    Score: 0.016
  15. Notch pathway activation induces neuroblastoma tumor cell growth arrest. Pediatr Blood Cancer. 2012 May; 58(5):682-9.
    View in: PubMed
    Score: 0.015
  16. Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia. Leuk Res. 2009 Oct; 33(10):1361-6.
    View in: PubMed
    Score: 0.013
  17. Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia. Leukemia. 2007 May; 21(5):906-11.
    View in: PubMed
    Score: 0.011
  18. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Cancer Res. 2004 Apr 01; 64(7):2411-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.